Skip to main content
. 2022 May 6;12(5):417. doi: 10.3390/metabo12050417

Table 1.

Anthropometric data, eating behavior and metabolic profile of the study cohort (n = 23).

Good Responder
n = 11
Bad Responder
n = 12
Good Responder vs.
Bad Responder
Clinical Characteristics
Sex (female/male)—n (%) 7 (64)/4 (36) 9 (75)/3 (25)
Smokers—n (%) 4 (36) 2 (17)
Diabetic—n (%)
 Before surgery (reported/A1c > 6.5%)
 After surgery (reported/A1c > 6.5%)
4 (36)/4 (36)
2 (18)/1 (9)
6 (50)/3 (25)
4 (33)/(3 (25)
mean/median * SD/IQR * mean/median SD/IQR p-value
Education Years—yr 13 13–15.5 13 13––13 0.26
Age at test date—yr 52.9 ± 9.5 54.1 ± 10.6 0.78
Time after surgery—yr 4.3 ± 1.2 4.6 ± 1.5 0.60
Excess Weight Loss (EWL) at test date—% 93.0 ± 4.3 19.5 ± 13.3 <0 .0001
Body weight—kg
 Before surgery
 Nadir
 At test date
 Change from baseline

133.4
69.9
76.6
−56.8

± 22.4
± 5.8
± 7.6
± 18.6

145.7
110.4
130.3
−15.5

± 19.5
± 15.9
± 17.6
± 10.9

0.17
<0.0001
<0.0001
<0.0001
BMI—kg/m2
 Before surgery
 Nadir
 At test date
 Change from baseline

46.5
24.4
26.6
−19.8

± 7.5
± 1.8
± 1.2
± 6.7

52.7
39.9
47.2
−5.5

± 6.6
± 4.4
± 6.4
± 3.9

0.04
<0.0001
<0.0001
<0.0001
Questionnaire Scores at test date
Fat and Sugar Intake (DFS-Q All)
 Fat
 Sugar
 Fat and Sugar
50
23
9.8
16.3
± 10
± 3.9
± 3.4
± 4.7
47
24
10.7
12.8
± 6.1
± 4.6
± 4.0
± 4.3
0.43
0.71
0.59
0.09
Emotional Eating (DEB-Q-EE) 1.5 1.0–2.2 2.0 1.1–2.9 0.54
Chronic Stress (TICS) 14 10–19 15 7.3–18 0.91
Metabolic Profile
Alanine transaminase—μkat/L
 Before surgery
 At test date
 Change from baseline

0.42
0.40
−0.05

0.33–0.92
0.29–0.47
−0.49 to 0.03

0.56
0.34
−0.2

0.38–1.1
0.31–0.66
−0.64 to −0.02

0.48
0.76
0.28
γ-glutamyl transferase—μkat/L
 Before surgery
 At test date
 Change from baseline

0.40
0.21
−0.17

0.28–0.70
0.13–0.42
−0.33 to −0.1

0.53
0.41
−0.12

0.360.79
0.25–1.20
−0.20 to 0.32

0.52
0.05
0.16
Fasting Glucose—mmol/L
 Before surgery
 At test date
 Change from baseline

5.7
5.0
−0.62

4.9–7.3
4.6–5.3
−2.3 to −0.1

6.5
5.4
−0.31

5.2–11
5.2–8.5
−2.5 to 0.03

0.24
0.02
0.69
Hemoglobin A1c—%
 Before surgery
 At test date
 Change from baseline

5.6
5.0
−0.32

5.0–7.0
4.8–5.6
−1.56 to −0.07

5.6
5.7
−0.4

5.3–8.5
5.2–6.6
−1.79 to 0.32

0.55
0.03
0.99
Insulin Resistance (HOMA-IR)
 Before surgery
 At test date
 Change from baseline

4.9
1.6
−2.6

2.4–18
1.1–2.5
−13.5 to −0.7

6.3
2.7
−3.3

3.9–11
1.8–3.1
−6.2 to −1.2

0.56
0.09
0.99
Triglycerides—mmol/L
 Before surgery
 At test date
 Change from baseline

1.3
0.94
−0.4

0.97–1.7
0.63–1.2
−0.64 to −0.08

1.4
1.3
−0.17

0.95–3.3
1.2–1.3
−1.78 to 0.15

0.85
0.02
0.69
Low Density Lipoprotein—mmol/L
 Before surgery
 At test date
 Change from baseline

2.5
2.2
−0.29

± 0.57
± 0.54
± 0.62

2.9
2.5
−0.48

± 1.3
± 0.57
± 0.93

0.37
0.28
0.58
High Density Lipoprotein—mmol/L
 Before surgery
 At test date
 Change from baseline

0.93
1.5
0.6

± 0.23
± 0.33
± 0.27

1.1
1.5
0.28

0.26
± 0.33
±0.3

0.09
0.70
0.02
C-reactive Protein—mg/L
 Before surgery
 At test date
 Change from baseline

5.0
0.3
−3.5

1.6–7.9
0.3–0.3
−7.6 to −1.3

9.7
2.0
−5.0

4.9–20
1.3–13
−9.9 to 2.0

0.10
<0.0001
0.79

* Data are presented as median and interquartile range (IQR) for non-normally distributed parameters and mean ± standard deviation (SD) for normally distributed parameters. Values with range are median and IQR, plus–minus values are means ± SD. Significant values p < 0.05 are printed in bold. Laboratory values are expressed in SI-values. Questionnaires: Dutch Eating Behaviour Questionnaire–Emotional Eating subscale (DEBQ-EE); Dietary Fat and Free Sugar Questionnaire ((DFS); Trier Inventory for Chronic Stress Screening Scale (TICS). BMI, body mass index; CRP, C-reactive protein; excess weight loss; HOMA-IR, homeostasis model assessment for insulin resistance; kg, kilograms; yr, years.